Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Deborah Cory-Slechta
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Living Beings
Chemicals & Drugs
Activities & Behaviors
Physiology
Concepts & Ideas
Disorders
Anatomy
Procedures
Sign-in to see full Profile
Network (preview)
25
Thiruchelvam, Mona
17
Richfield, Eric
9
Brockel, BJ
8
Virgolini, Miriam
7
Brooks, Andrew
7
Weston, Doug
7
Federoff, Howard
6
Weiss, Bernard
6
Barlow, Brian
5
Baggs, Raymond
5
O'Mara, DJ
5
Reeves, Ruth
4
Rossi-George, Alba
4
Canfield, Richard
4
Bauter, Mark
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Deborah Cory-Slechta (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Cory-Slechta D A; Virgolini M B; Rossi-George A; Weston D; Thiruchelvam M
Experimental manipulations blunt time-induced changes in brain monoamine levels and completely reverse stress, but not Pb+/-stress-related modifications to these trajectories.
Behavioural brain research 2009;205(1):76-87.
-
2009: van Wijngaarden Edwin; Campbell James R; Cory-Slechta Deborah A
Bone lead levels are associated with measures of memory impairment in older adults.
Neurotoxicology 2009;30(4):572-80.
-
2008: Virgolini M B; Rossi-George A; Weston D; Cory-Slechta D A
Influence of low level maternal Pb exposure and prenatal stress on offspring stress challenge responsivity.
Neurotoxicology 2008;29(6):928-39.
-
2008: Cory-Slechta D A; Weiss B; Cranmer J
The environmental etiologies of neurobehavioral deficits and disorders: weaving complex outcomes and risk modifiers into the equation.
Neurotoxicology 2008;29(5):759-60.
-
2008: Weiss Bernard; Cory-Slechta Deborah; Gilbert Steven G; Mergler Donna; Miller Elise; Miller Claudia; Newland M Christopher; Rice Deborah; Schettler Ted
The new tapestry of risk assessment.
Neurotoxicology 2008;29(5):883-90.
-
2008: Virgolini M B; Rossi-George A; Lisek R; Weston D D; Thiruchelvam M; Cory-Slechta D A
CNS effects of developmental Pb exposure are enhanced by combined maternal and offspring stress.
Neurotoxicology 2008;29(5):812-27.
-
2008: Lanphear Bruce P; Hornung Richard W; Khoury Jane; Dietrich Kim N; Cory-Slechta Deborah A; Canfield Richard L
The conundrum of unmeasured confounding: Comment on: "Can some of the detrimental neurodevelopmental effects attributed to lead be due to pesticides? by Brian Gulson".
The Science of the total environment 2008;396(2-3):196-200.
-
2008: Cory-Slechta Deborah A; Thiruchelvam Mona; Di Monte Donato A
Letter regarding: "Paraquat: the red herring of Parkinson's disease research".
Toxicological sciences : an official journal of the Society of Toxicology 2008;103(1):215-6; author reply 217-8.
-
2008: Jusko Todd A; Henderson Charles R; Lanphear Bruce P; Cory-Slechta Deborah A; Parsons Patrick J; Canfield Richard L
Blood lead concentrations < 10 microg/dL and child intelligence at 6 years of age.
Environmental health perspectives 2008;116(2):243-8.
-
2008: Cory-Slechta Deborah A; Virgolini Miriam B; Rossi-George Alba; Thiruchelvam Mona; Lisek Renata; Weston Douglas
Lifetime consequences of combined maternal lead and stress.
Basic & clinical pharmacology & toxicology 2008;102(2):218-27.
-
2007: Froehlich Tanya E; Lanphear Bruce P; Dietrich Kim N; Cory-Slechta Deborah A; Wang Ning; Kahn Robert S
Interactive effects of a DRD4 polymorphism, lead, and sex on executive functions in children.
Biological psychiatry 2007;62(3):243-9.
-
2007: Barlow Brian K; Cory-Slechta Deborah A; Richfield Eric K; Thiruchelvam Mona
The gestational environment and Parkinson's disease: evidence for neurodevelopmental origins of a neurodegenerative disorder.
Reproductive toxicology (Elmsford, N.Y.) 2007;23(3):457-70.
-
2007: Gray Joshua P; Heck Diane E; Mishin Vladimir; Smith Peter J S; Hong Jun-Yan; Thiruchelvam Mona; Cory-Slechta Deborah A; Laskin Debra L; Laskin Jeffrey D
Paraquat increases cyanide-insensitive respiration in murine lung epithelial cells by activating an NAD(P)H:paraquat oxidoreductase: identification of the enzyme as thioredoxin reductase.
The Journal of biological chemistry 2007;282(11):7939-49.
-
2006: Davidson Philip W; Weiss Bernard; Beck Christopher; Cory-Slechta Deborah A; Orlando Mark; Loiselle David; Young Edna Carter; Sloane-Reeves Jean; Myers Gary J
Development and validation of a test battery to assess subtle neurodevelopmental differences in children.
Neurotoxicology 2006;27(6):951-69.
-
2006: Virgolini M B; Bauter M R; Weston D D; Cory-Slechta D A
Permanent alterations in stress responsivity in female offspring subjected to combined maternal lead exposure and/or stress.
Neurotoxicology 2006;27(1):11-21.
-
2005: Virgolini Miriam B; Chen Kevin; Weston Doug D; Bauter Mark R; Cory-Slechta Deborah A
Interactions of chronic lead exposure and intermittent stress: consequences for brain catecholamine systems and associated behaviors and HPA axis function.
Toxicological sciences : an official journal of the Society of Toxicology 2005;87(2):469-82.
-
2005: Cory-Slechta Deborah A; Thiruchelvam Mona; Barlow Brian K; Richfield Eric K
Developmental pesticide models of the Parkinson disease phenotype.
Environmental health perspectives 2005;113(9):1263-70.
-
2005: Cory-Slechta Deborah A
Studying toxicants as single chemicals: does this strategy adequately identify neurotoxic risk?
Neurotoxicology 2005;26(4):491-510.
-
2005: Carmouche Jonathan J; Puzas J Edward; Zhang Xinping; Tiyapatanaputi Prarop; Cory-Slechta Deborah A; Gelein Robert; Zuscik Michael; Rosier Randy N; Boyce Brendan F; O'Keefe Regis J; Schwarz Edward M
Lead exposure inhibits fracture healing and is associated with increased chondrogenesis, delay in cartilage mineralization, and a decrease in osteoprogenitor frequency.
Environmental health perspectives 2005;113(6):749-55.
-
2005: Rodriguez Veronica M; Thiruchelvam Mona; Cory-Slechta Deborah A
Sustained exposure to the widely used herbicide atrazine: altered function and loss of neurons in brain monoamine systems.
Environmental health perspectives 2005;113(6):708-15.
-
2005: Mhyre T R; Chesler E J; Thiruchelvam M; Lungu C; Cory-Slechta D A; Fry J D; Richfield E K
Heritability, correlations and in silico mapping of locomotor behavior and neurochemistry in inbred strains of mice.
Genes, brain, and behavior 2005;4(4):209-28.
-
2005: Thiruchelvam Mona; Prokopenko Olga; Cory-Slechta Deborah A; Buckley Brian; Mirochnitchenko Oleg
Overexpression of superoxide dismutase or glutathione peroxidase protects against the paraquat + maneb-induced Parkinson disease phenotype.
The Journal of biological chemistry 2005;280(23):22530-9.
-
2005: Cory-Slechta Deborah A; Thiruchelvam Mona; Richfield Eric K; Barlow Brian K; Brooks Andrew I
Developmental pesticide exposures and the Parkinson's disease phenotype.
Birth defects research. Part A, Clinical and molecular teratology 2005;73(3):136-9.
-
2005: Barlow Brian K; Lee Donna W; Cory-Slechta Deborah A; Opanashuk Lisa A
Modulation of antioxidant defense systems by the environmental pesticide maneb in dopaminergic cells.
Neurotoxicology 2005;26(1):63-75.
-
2004: Reeves Ruth; Thiruchelvam Mona; Richfield Eric K; Cory-Slechta Deborah A
The effect of developmental exposure to the fungicide triadimefon on behavioral sensitization to triadimefon during adulthood.
Toxicology and applied pharmacology 2004;200(1):54-63.
-
2004: Reeves R; Thiruchelvam M; Cory-Slechta D A
Expression of behavioral sensitization to the cocaine-like fungicide triadimefon is blocked by pretreatment with AMPA, NMDA and DA D1 receptor antagonists.
Brain research 2004;1008(2):155-67.
-
2004: Cory-Slechta Deborah A; Virgolini Miriam B; Thiruchelvam Mona; Weston Doug D; Bauter Mark R
Maternal stress modulates the effects of developmental lead exposure.
Environmental health perspectives 2004;112(6):717-30.
-
2004: Reeves R; Thiruchelvam M; Cory-Slechta D A
Development of behavioral sensitization to the cocaine-like fungicide triadimefon is prevented by AMPA, NMDa, DA D1 but not DA D2 receptor antagonists.
Toxicological sciences : an official journal of the Society of Toxicology 2004;79(1):123-36.
-
2004: Thiruchelvam M J; Powers J M; Cory-Slechta D A; Richfield E K
Risk factors for dopaminergic neuron loss in human alpha-synuclein transgenic mice.
The European journal of neuroscience 2004;19(4):845-54.
-
2004: Barlow Brian K; Richfield Eric K; Cory-Slechta Deborah A; Thiruchelvam Mona
A fetal risk factor for Parkinson's disease.
Developmental neuroscience 2004;26(1):11-23.
-
2004: Canfield Richard L; Gendle Mathew H; Cory-Slechta Deborah A
Impaired neuropsychological functioning in lead-exposed children.
Developmental neuropsychology 2004;26(1):513-40.
-
2003: Reeves R; Thiruchelvam M; Baggs R B; Cory-Slechta D A
Interactions of paraquat and triadimefon: behavioral and neurochemical effects.
Neurotoxicology 2003;24(6):839-50.
-
2003: Reeves Ruth; Thiruchelvam Mona; Richfield Eric K; Cory-Slechta Deborah A
Behavioral sensitization and long-term neurochemical alterations associated with the fungicide triadimefon.
Pharmacology, biochemistry, and behavior 2003;76(2):315-26.
-
2003: Thiruchelvam Mona; McCormack Alison; Richfield Eric K; Baggs Raymond B; Tank A William; Di Monte Donato A; Cory-Slechta Deborah A
Age-related irreversible progressive nigrostriatal dopaminergic neurotoxicity in the paraquat and maneb model of the Parkinson's disease phenotype.
The European journal of neuroscience 2003;18(3):589-600.
-
2003: Barlow Brian K; Thiruchelvam Mona J; Bennice Lisa; Cory-Slechta Deborah A; Ballatori Nazzareno; Richfield Eric K
Increased synaptosomal dopamine content and brain concentration of paraquat produced by selective dithiocarbamates.
Journal of neurochemistry 2003;85(4):1075-86.
-
2003: Canfield Richard L; Henderson Charles R; Cory-Slechta Deborah A; Cox Christopher; Jusko Todd A; Lanphear Bruce P
Intellectual impairment in children with blood lead concentrations below 10 microg per deciliter.
The New England journal of medicine 2003;348(16):1517-26.
-
2003: Cory-Slechta Deborah A
Lead-induced impairments in complex cognitive function: offerings from experimental studies.
Child neuropsychology : a journal on normal and abnormal development in childhood and adolescence 2003;9(1):54-75.
-
2003: Bauter M R; Brockel B J; Pankevich D E; Virgolini M B; Cory-Slechta D A
Glutamate and dopamine in nucleus accumbens core and shell: sequence learning versus performance.
Neurotoxicology 2003;24(2):227-43.
-
2002: Thiruchelvam Mona; Richfield Eric K; Goodman Becky M; Baggs Raymond B; Cory-Slechta Deborah A
Developmental exposure to the pesticides paraquat and maneb and the Parkinson's disease phenotype.
Neurotoxicology 2002;23(4-5):621-33.
-
2002: Cory-Slechta Deborah A; Brockel B J; O'Mara D J
Lead exposure and dorsomedial striatum mediation of fixed interval schedule-controlled behavior.
Neurotoxicology 2002;23(3):313-27.
-
2002: McCormack Alison L; Thiruchelvam Mona; Manning-Bog Amy B; Thiffault Christine; Langston J William; Cory-Slechta Deborah A; Di Monte Donato A
Environmental risk factors and Parkinson's disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat.
Neurobiology of disease 2002;10(2):119-27.
-
2002: Richfield Eric K; Thiruchelvam Mona J; Cory-Slechta Deborah A; Wuertzer Charles; Gainetdinov Raul R; Caron Marc G; Di Monte Donato A; Federoff Howard J
Behavioral and neurochemical effects of wild-type and mutated human alpha-synuclein in transgenic mice.
Experimental neurology 2002;175(1):35-48.
-
2002: Brooks Andrew I; Stein Colleen S; Hughes Stephanie M; Heth Jason; McCray Paul M; Sauter Sybille L; Johnston Julie C; Cory-Slechta Deborah A; Federoff Howard J; Davidson Beverly L
Functional correction of established central nervous system deficits in an animal model of lysosomal storage disease with feline immunodeficiency virus-based vectors.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(9):6216-21.
-
2001: Zuch C L; Cory-Slechta D A
Stimulus properties of 7-OH-DPAT versus auto- and postsynaptic receptor-specific doses of quinpirole.
Pharmacology, biochemistry, and behavior 2001;68(3):469-79.
-
2001: Cory-Slechta D A; Crofton K M; Foran J A; Ross J F; Sheets L P; Weiss B; Mileson B
Methods to identify and characterize developmental neurotoxicity for human health risk assessment. I: behavioral effects.
Environmental health perspectives 2001;109 Suppl 1():79-91.
-
2000: Davidson P W; Weiss B; Myers G J; Cory-Slechta D A; Brockel B J; Young E C; Orlando M; Loiselle D; Palumbo D; Pittelli R; Sloan-Reeves J
Evaluation of techniques for assessing neurobehavioral development in children.
Neurotoxicology 2000;21(6):957-72.
-
2000: Thiruchelvam M; Richfield E K; Baggs R B; Tank A W; Cory-Slechta D A
The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: implications for Parkinson's disease.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2000;20(24):9207-14.
-
2000: Brooks A I; Cory-Slechta D A; Bowers W J; Murg S L; Federoff H J
Enhanced learning in mice parallels vector-mediated nerve growth factor expression in hippocampus.
Human gene therapy 2000;11(17):2341-52.
-
2000: Brooks A I; Cory-Slechta D A; Federoff H J
Gene-experience interaction alters the cholinergic septohippocampal pathway of mice.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(24):13378-83.
-
2000: Brooks A I; Cory-Slechta D A; Murg S L; Federoff H J
Repeated acquisition and performance chamber for mice: a paradigm for assessment of spatial learning and memory.
Neurobiology of learning and memory 2000;74(3):241-58.
-
2000: Thiruchelvam M; Brockel B J; Richfield E K; Baggs R B; Cory-Slechta D A
Potentiated and preferential effects of combined paraquat and maneb on nigrostriatal dopamine systems: environmental risk factors for Parkinson's disease?
Brain research 2000;873(2):225-34.
-
2000: Evans S B; Cory-Slechta D A
Prefrontal cortical manipulations alter the effects of intra-ventral striatal dopamine antagonists on fixed-interval performance in the rat.
Behavioural brain research 2000;107(1-2):45-58.
-
1999: Brockel B J; Cory-Slechta D A
The effects of postweaning low-level Pb exposure on sustained attention: a study of target densities, stimulus presentation rate, and stimulus predictability.
Neurotoxicology 1999;20(6):921-33.
-
1999: Brockel B J; Cory-Slechta D A
Lead-induced decrements in waiting behavior: involvement of D2-like dopamine receptors.
Pharmacology, biochemistry, and behavior 1999;63(3):423-34.
-
1999: Cory-Slechta D A; O'Mara D J; Brockel B J
Learning versus performance impairments following regional administration of MK-801 into nucleus accumbens and dorsomedial striatum.
Behavioural brain research 1999;102(1-2):181-94.
-
1999: Brooks A I; Chadwick C A; Gelbard H A; Cory-Slechta D A; Federoff H J
Paraquat elicited neurobehavioral syndrome caused by dopaminergic neuron loss.
Brain research 1999;823(1-2):1-10.
-
1998: Cory-Slechta D A; O'Mara D J; Brockel B J
Nucleus accumbens dopaminergic medication of fixed interval schedule-controlled behavior and its modulation by low-level lead exposure.
The Journal of pharmacology and experimental therapeutics 1998;286(2):794-805.
-
1998: Brockel B J; Cory-Slechta D A
Lead, attention, and impulsive behavior: changes in a fixed-ratio waiting-for-reward paradigm.
Pharmacology, biochemistry, and behavior 1998;60(2):545-52.
-
1998: Zuch C L; O'Mara D J; Cory-Slechta D A
Low-level lead exposure selectively enhances dopamine overflow in nucleus accumbens: an in vivo electrochemistry time course assessment.
Toxicology and applied pharmacology 1998;150(1):174-85.
-
1998: Maines M D; Polevoda B; Coban T; Johnson K; Stoliar S; Huang T J; Panahian N; Cory-Slechta D A; McCoubrey W K
Neuronal overexpression of heme oxygenase-1 correlates with an attenuated exploratory behavior and causes an increase in neuronal NADPH diaphorase staining.
Journal of neurochemistry 1998;70(5):2057-69.
-
1997: McCoy L; Richfield E K; Cory-Slechta D A
Regional decreases in alpha-[3H]amino-3-hydroxy-5-methylisoxazole-4-propionic acid ([3H]AMPA) and 6-[3H]cyano-7-nitroquinoxaline-2,3-dione ([3H]CNQX) binding in response to chronic low-level lead exposure: reversal versus potentiation by chronic dopamine agonist treatment.
Journal of neurochemistry 1997;69(6):2466-76.
-
1997: Cory-Slechta D A; Flaugher C L; Evans S B; Pokora M J; Greenamyre J T
Susceptibility of adult rats to lead-induced changes in NMDA receptor complex function.
Neurotoxicology and teratology 1997;19(6):517-30.
-
1997: Cory-Slechta D A; Pazmino R; Bare C
The critical role of nucleus accumbens dopamine systems in the mediation of fixed interval schedule-controlled operant behavior.
Brain research 1997;764(1-2):253-6.
-
1997: Cory-Slechta D A; McCoy L; Richfield E K
Time course and regional basis of Pb-induced changes in MK-801 binding: reversal by chronic treatment with the dopamine agonist apomorphine but not the D1 agonist SKF-82958.
Journal of neurochemistry 1997;68(5):2012-23.
-
1997: Cory-Slechta D A; Garcia-Osuna M; Greenamyre J T
Lead-induced changes in NMDA receptor complex binding: correlations with learning accuracy and with sensitivity to learning impairments caused by MK-801 and NMDA administration.
Behavioural brain research 1997;85(2):161-74.
-
1997: Brooks A I; Muhkerjee B; Panahian N; Cory-Slechta D; Federoff H J
Nerve growth factor somatic mosaicism produced by herpes virus-directed expression of cre recombinase.
Nature biotechnology 1997;15(1):57-62.
-
1997: Cory-Slechta D A
Relationships between Pb-induced changes in neurotransmitter system function and behavioral toxicity.
Neurotoxicology 1997;18(3):673-88.
-
1997: Cory-Slechta D A
Postnatal lead exposure and MK-801 sensitivity.
Neurotoxicology 1997;18(1):209-20.
-
1996: Cory-Slechta D A; Zuch C L; Fox R A
Comparison of the stimulus properties of a pre- vs. a putative postsynaptic dose of quinpirole.
Pharmacology, biochemistry, and behavior 1996;55(3):423-32.
-
1996: Pokora M J; Richfield E K; Cory-Slechta D A
Preferential vulnerability of nucleus accumbens dopamine binding sites to low-level lead exposure: time course of effects and interactions with chronic dopamine agonist treatments.
Journal of neurochemistry 1996;67(4):1540-50.
-
1996: Cory-Slechta D A; Pokora M J; Preston R A
The effects of dopamine agonists on fixed interval schedule-controlled behavior are selectively altered by low-level lead exposure.
Neurotoxicology and teratology 1996;18(5):565-75.
-
1996: Cory-Slechta D A; Pokora M J; Johnson J L
Postweaning lead exposure enhances the stimulus properties of N-methyl-D-aspartate: possible dopaminergic involvement?
Neurotoxicology 1996;17(2):509-21.
-
1996: Cory-Slechta D A; Pokora M J; Fox R A; O'Mara D J
Lead-induced changes in dopamine D1 sensitivity: modulation by drug discrimination training.
Neurotoxicology 1996;17(2):445-57.
-
1995: Cory-Slechta D A
Bridging human and experimental animal studies of lead neurotoxicity: moving beyond IQ.
Neurotoxicology and teratology 1995;17(3):219-21; discussion 249-51.
-
1995: Cory-Slechta D A
MK-801 subsensitivity following postweaning lead exposure.
Neurotoxicology 1995;16(1):83-95.
-
1995: Cory-Slechta D A; Pokora M J
Lead-induced changes in muscarinic cholinergic sensitivity.
Neurotoxicology 1995;16(2):337-47.
-
1994: Cohn J; Cory-Slechta D A
Lead exposure potentiates the effects of NMDA on repeated learning.
Neurotoxicology and teratology 1994;16(5):455-65.
-
1994: Widzowski D V; Cory-Slechta D A
Homogeneity of regional brain lead concentrations.
Neurotoxicology 1994;15(2):295-307.
-
1994: Cohn J; Cory-Slechta D A
Assessment of the role of dopaminergic systems in lead-induced learning impairments using a repeated acquisition and performance baseline.
Neurotoxicology 1994;15(4):913-26.
-
1994: Widzowski D V; Finkelstein J N; Pokora M J; Cory-Slechta D A
Time course of postnatal lead-induced changes in dopamine receptors and their relationship to changes in dopamine sensitivity.
Neurotoxicology 1994;15(4):853-65.
-
1993: Widzowski D V; Cory-Slechta D A
Apparent mediation of the stimulus properties of a low dose of quinpirole by dopaminergic autoreceptors.
The Journal of pharmacology and experimental therapeutics 1993;266(2):526-34.
-
1993: Cohn J; Cory-Slechta D A
Subsensitivity of lead-exposed rats to the accuracy-impairing and rate-altering effects of MK-801 on a multiple schedule of repeated learning and performance.
Brain research 1993;600(2):208-18.
-
1993: Cohn J; Cox C; Cory-Slechta D A
The effects of lead exposure on learning in a multiple repeated acquisition and performance schedule.
Neurotoxicology 1993;14(2-3):329-46.
-
1993: Cory-Slechta D A; Widzowski D V; Pokora M J
Functional alterations in dopamine systems assessed using drug discrimination procedures.
Neurotoxicology 1993;14(2-3):105-14.
-
1992: Cory-Slechta D A; Pokora M J; Widzowski D V
Postnatal lead exposure induces supersensitivity to the stimulus properties of a D2-D3 agonist.
Brain research 1992;598(1-2):162-72.
-
1992: Cohn J; Widzowski D V; Cory-Slechta D A
Lead retards development of Drosophila melanogaster.
Comparative biochemistry and physiology. C, Comparative pharmacology and toxicology 1992;102(1):45-9.
-
1992: Cohn J; Ziriax J M; Cox C; Cory-Slechta D A
Comparison of error patterns produced by scopolamine and MK-801 on repeated acquisition and transition baselines.
Psychopharmacology 1992;107(2-3):243-54.
-
1991: Cory-Slechta D A; Widzowski D V
Low level lead exposure increases sensitivity to the stimulus properties of dopamine D1 and D2 agonists.
Brain research 1991;553(1):65-74.
-
1991: Cory-Slechta D A; Pokora M J; Widzowski D V
Behavioral manifestations of prolonged lead exposure initiated at different stages of the life cycle: II. Delayed spatial alternation.
Neurotoxicology 1991;12(4):761-76.
-
1991: Cory-Slechta D A; Pokora M J
Behavioral manifestations of prolonged lead exposure initiated at different stages of the life cycle: I. Schedule-controlled responding.
Neurotoxicology 1991;12(4):745-60.
-
1990: Cory-Slechta D A
Lead exposure during advanced age: alterations in kinetics and biochemical effects.
Toxicology and applied pharmacology 1990;104(1):67-78.
-
1990: Cory-Slechta D A
Alterations in tissue Pb distribution and hematopoietic indices during advanced age.
Archives of toxicology 1990;64(1):31-7.
-
1990: Cory-Slechta D A
Exposure duration modifies the effects of low level lead of fixed-interval performance.
Neurotoxicology 1990;11(3):427-41.
-
1989: Cory-Slechta D A; Weiss B; Cox C
Tissue distribution of Pb in adult vs. old rats: a pilot study.
Toxicology 1989;59(2):139-50.
-
1989: Cory-Slechta D A; Widzowski D V; Newland M C
Behavioral differentiation of the stimulus properties of a dopaminergic D1 agonist from a D2 agonist.
The Journal of pharmacology and experimental therapeutics 1989;250(3):800-8.
-
1989: Cory-Slechta D A
Behavioral measures of neurotoxicity.
Neurotoxicology 1989;10(2):271-95.
-
1989: Cory-Slechta D A; Weiss B
Efficacy of the chelating agent CaEDTA in reversing lead-induced changes in behavior.
Neurotoxicology 1989;10(4):685-97.
-
1988: Cory-Slechta D A
Mobilization of lead over the course of DMSA chelation therapy and long-term efficacy.
The Journal of pharmacology and experimental therapeutics 1988;246(1):84-91.
-
1987: Cory-Slechta D A; Weiss B; Cox C
Mobilization and redistribution of lead over the course of calcium disodium ethylenediamine tetraacetate chelation therapy.
The Journal of pharmacology and experimental therapeutics 1987;243(3):804-13.
Sign-in to see more